Manufacturing

Biopharma continues to adopt single-use technologies, but also seeks more innovation and improvements in products.

An increased need for higher-capacity resins and the demand for smaller batches has made disposable chromatography a more viable option.

Dual sourcing is one of many possible solutions to securing the supply chain.

Representatives from industry supplier companies address innovations, reliability, barriers to adoption, and the role of singIe-use bioreactors in bioprocessing.

New publications from BPSA and PDA highlight best practices for particulate control, quality agreements, and implementation strategies.

The new location will increase Bristol-Myers Squibb's biologics manufacturing capacity.

Construction has started on Novo Nordisk's laboratories for diabetes research in Denmark.

For cellular therapies to become a viable treatment for large-sized patient groups, steps need to be taken to develop an efficient manufacturing and supply system to minimise the cost of goods.

Sartorius opened a new application center at its offices in Shanghai for product demonstrations, trial runs, and training sessions.

Cellular therapy developers learn process development strategies from pharma industry experiences.

Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.

The authors offer insight into cell therapy manufacturing, vector production, and the safety aspects of testing for characterization.

The final guidance explains some principles for developing biosimilars and establishes some rules about extrapolation across indications for various medical conditions.

Bristol-Myers Squibb announced that they have reached an agreement with F-star Alpha, giving BMS the exclusive option to acquire F-star's HER2-targeted breast and gastric cancer treatment.

The new Argos biomanufacturing facility in North Carolina will include automated production using the company's Arcelis technology.

Celgene expands its oncology drug discovery and development portfolio through a new partnership with Sutro.

The latest Ebola epidemic sheds light on the delicate processes surrounding the manufacture of genetically modified live cells for biopharmaceutical production.

The renovation to Roche's historic office building in Basel, Switzerland will feature sustainable workplaces and a state-of-the-art research center.

The agency recommends that companies developing drugs to treat Ebola apply for orphan drug designation.

A Priority Review voucher Sanofi and Regeneron purchased from BioMarin pharmaceuticals may put their mAb ahead of Amgen's in the market.

Lilly announces the closure of its Guayama, Puerto Rico manufacturing facility amid continued investments at other plants.

Personalized immunotherapy treatments help 90% of acute lymphoblastic leukemia patients achieve remission in a new study.

The Apollo platform can be used throughout a product?s entire lifecycle.

Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.

The EZ-Fit Filtration Unit, a ready-to-use, disposable filtration device for bioburden testing from EMD Millipore, the Life Science division of Merck KGaA, increases reliability and streamlines workflows.